NCT03885076View on ClinicalTrials.gov

Gamma Delta T Cells in AML

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

August 23, 2018

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2021

Conditions
Acute Myeloid Leukemia
Interventions
PROCEDURE

Blood collection and bone marrow aspirate

Blood and bone marrow samples will be collected for the trial alongside routine tests.

Trial Locations (1)

SM2 5PT

RECRUITING

The Royal Marsden NHS Foundation Trust, Sutton

Sponsors

Collaborators (1)

TC Biopharm
All Listed Sponsors
collaborator

TC Biopharm

INDUSTRY

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT03885076 - Gamma Delta T Cells in AML | Biotech Hunter | Biotech Hunter